Data as of Apr 17
| +2.59 / +1.09%|
The 6 analysts offering 12-month price forecasts for Intercept Pharmaceuticals Inc have a median target of 507.50, with a high estimate of 700.00 and a low estimate of 450.00. The median estimate represents a +111.12% increase from the last price of 240.39.
The current consensus among 6 polled investment analysts is to Buy stock in Intercept Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.